Skip to main content

Shaw Timothy's Form 4 filing

Marimed Inc. (MRMD) · filed Mar 11, 2024

Accession no.
0001522767-24-000013
Filed
Mar 11, 2024, 5:30 PM ET
Trade date
Mar 7, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.60K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shaw TimothyCIK 0001866577Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 7, 2024Common stockMOption exerciseAcquired+43,333–F1–8,492,420Direct
Mar 7, 2024Common stockSSaleDisposed−15,348$0.2348−$3,603.718,477,072Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 7, 2024Common Stock, par value $.001 per shareMOption exerciseDisposed−43,333$0.00$086,667Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

RSUs convert to shares of common stock on a one-for-one basis.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)